Why 3M Shares Are Sliding Today

3M Company (NYSE: MMM) shares are trading lower Tuesday after the company reported worse-than-expected topline results and cut its full-year earnings outlook.

3M Company (NYSE:MMM) shares are trading lower Tuesday after the company reported worse-than-expected topline results and cut its full-year earnings outlook.

3M said third-quarter revenue decreased 4% year-over-year to $8.6 billion, which missed average analyst estimates of $8.73 billion, according to Benzinga Pro. The company reported quarterly earnings of $2.69 per share, which beat average estimates of $2.62 per share. 

“We continue to execute our strategies and deliver for our customers in a highly uncertain environment. Excluding the impact of the decline in disposable respirator sales, our team posted over 3 percent organic growth. We delivered sequential and year-over-year margin expansion, amidst macroeconomic challenges and the strengthening U.S. dollar,” said Mike Roman, chairman and CEO of 3M.

3M said it now expects organic sales growth of 1.5% to 2% versus prior expectations of 1.5% to 3.5%. 

3M also cut its full-year adjusted earnings guidance from a range of $10.30 to $10.80 per share to a range of $10.10 to $10.35 per share versus average analyst estimates of $10.29 per share. 

See Also: Why Coca-Cola Stock Is Rising Today

MMM Price Action: 3M has a 52-week high of $181.78 and a 52-week low of $107.07.

The stock was down 2.67% at $115.23 Tuesday morning. 

Photo: courtesy of 3M.

Total
0
Shares
Related Posts
Read More

What’s Going On With ImmunityBio Stock?

ImmunityBio said the QUILT 3.055 trial shows median overall survival almost double that of standard of care chemotherapy in 2nd- and 3rd-line non-small cell lung cancer (NSCLC) patients whose cancer did not respond to checkpoint inhibitors with or without chemotherapy. 

IBRX